Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,982 | 658 | 99.3% |
| Education | $108.90 | 3 | 0.7% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,185 | 145 | $0 (2024) |
| Amgen Inc. | $1,639 | 72 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,535 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,445 | 34 | $0 (2024) |
| Lilly USA, LLC | $1,349 | 86 | $0 (2024) |
| ABBVIE INC. | $757.08 | 26 | $0 (2024) |
| PFIZER INC. | $711.68 | 39 | $0 (2024) |
| Merck Sharp & Dohme LLC | $527.04 | 28 | $0 (2024) |
| Amarin Pharma Inc. | $468.10 | 17 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $369.86 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,424 | 90 | Lilly USA, LLC ($370.78) |
| 2023 | $1,944 | 92 | Lilly USA, LLC ($343.40) |
| 2022 | $2,006 | 103 | Novo Nordisk Inc ($377.94) |
| 2021 | $2,079 | 86 | Novo Nordisk Inc ($423.87) |
| 2020 | $1,002 | 50 | Novo Nordisk Inc ($285.14) |
| 2019 | $1,701 | 69 | Amgen Inc. ($335.85) |
| 2018 | $1,930 | 82 | Amgen Inc. ($313.22) |
| 2017 | $2,005 | 93 | Boehringer Ingelheim Pharmaceuticals, Inc. ($312.49) |
All Payment Transactions
665 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $20.49 | General |
| Category: Medical Device | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: VACCINE | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Biological | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $40.95 | General |
| Category: Medical Device | ||||||
| 10/28/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: VACCINES | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Diabetes Care | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $103.46 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Philips North America LLC | (CK6) Holter (Device) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Medical Device | ||||||
| 09/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiology | ||||||
| 09/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: DIABETES | ||||||
| 09/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: PAIN | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,161 | 5,866 | $396,399 | $152,299 |
| 2022 | 25 | 3,100 | 5,721 | $380,188 | $136,671 |
| 2021 | 24 | 3,281 | 6,111 | $413,388 | $155,972 |
| 2020 | 23 | 3,224 | 5,911 | $384,632 | $131,641 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 338 | 916 | $160,300 | $79,295 | 49.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 318 | 653 | $41,139 | $8,567 | 20.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $9,600 | $8,235 | 85.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 338 | 970 | $14,550 | $8,148 | 56.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 321 | 783 | $34,452 | $8,104 | 23.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 314 | 438 | $28,470 | $7,209 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 116 | $13,920 | $6,418 | 46.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 319 | 486 | $15,552 | $3,698 | 23.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 119 | 334 | $20,708 | $3,180 | 15.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 44 | 44 | $4,092 | $3,093 | 75.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 19 | $3,800 | $3,049 | 80.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 143 | 143 | $9,724 | $2,706 | 27.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,340 | $2,153 | 92.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $2,016 | $1,270 | 63.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 50 | 81 | $4,860 | $1,082 | 22.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 24 | $2,640 | $948.98 | 35.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 31 | 42 | $2,856 | $756.84 | 26.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 24 | 26 | $2,340 | $754.26 | 32.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 301 | 338 | $9,802 | $743.60 | 7.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 73 | 77 | $3,850 | $657.08 | 17.1% |
| 83550 | Iron binding capacity | Office | 2023 | 48 | 76 | $2,280 | $651.32 | 28.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 30 | 33 | $2,079 | $487.74 | 23.5% |
| 83540 | Iron level | Office | 2023 | 48 | 76 | $2,280 | $481.84 | 21.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 23 | 41 | $1,435 | $362.44 | 25.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 12 | 15 | $450.00 | $124.35 | 27.6% |
About Dr. Christopher Guy, MD
Dr. Christopher Guy, MD is a Internal Medicine healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386639250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Guy, MD has received a total of $15,090 in payments from pharmaceutical and medical device companies, with $2,424 received in 2024. These payments were reported across 665 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($14,982).
As a Medicare-enrolled provider, Guy has provided services to 12,766 Medicare beneficiaries, totaling 23,609 services with total Medicare billing of $576,583. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Gainesville, FL
- Active Since 09/15/2005
- Last Updated 06/26/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1386639250
Products in Payments
- JARDIANCE (Drug) $1,463
- Ozempic (Drug) $808.27
- FARXIGA (Drug) $700.08
- MOUNJARO (Drug) $698.16
- EVENITY (Biological) $609.84
- ELIQUIS (Drug) $541.26
- Repatha (Biological) $523.56
- BREZTRI (Drug) $498.66
- Vascepa (Drug) $468.10
- NURTEC ODT (Drug) $384.07
- Rybelsus (Drug) $372.64
- Kerendia (Drug) $369.86
- TRULICITY (Drug) $317.22
- Aimovig (Biological) $308.77
- VRAYLAR (Drug) $301.35
- BELSOMRA (Drug) $293.77
- RYBELSUS (Drug) $284.57
- Wegovy (Drug) $277.09
- NEXLIZET (Drug) $245.64
- ENTRESTO (Drug) $238.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gainesville
Dr. Vivek Sambhara, M.d, M.D
Internal Medicine — Payments: $217,213
Dr. Christopher Recknor, M.d, M.D
Internal Medicine — Payments: $91,144
Dr. Carlos Alviar Restrepo, Md, MD
Internal Medicine — Payments: $90,926
Dr. Alanna Morris, M.d, M.D
Internal Medicine — Payments: $85,602
Brian Ramnaraign, M.d, M.D
Internal Medicine — Payments: $65,740
Ilie Barb, M.d, M.D
Internal Medicine — Payments: $55,024